NEW YORK, NY / ACCESSWIRE / August 6, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Insperity, Inc. (NYSE:NSP)
Investors Affected: February 11, 2019 - February 11, 2020
A class action has commenced on behalf of certain shareholders in Insperity, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had failed to negotiate appropriate rates with its customers for employee benefit plans and did not adequately disclose the risk of large medical claims from these plans; (b) Insperity was experiencing an adverse trend of large medical claims; (c) as a mitigating measure, the Company would be forced to increase the cost of its employee benefit plans, causing stunted customer growth and reduced customer retention; and (d) the foregoing issues were reasonably likely to, and would, materially impact Insperity's financial results.
Shareholders may find more information at https://securitiesclasslaw.com/securities/insperity-inc-loss-submission-form/?id=8422&from=1
Endo International Plc (NASDAQ:ENDP)
Investors Affected: August 8, 2017 - June 10, 2020
A class action has commenced on behalf of certain shareholders in Endo International Plc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/endo-international-plc-loss-submission-form/?id=8422&from=1
United States Oil Fund, LP (NYSE:USO)
The Lawsuit is on behalf of shareholders of United States Oil Fund, LP who purchased shares between March 19, 2020 and April 28, 2020 and/or pursuant or otherwise traceable to the Fund's March 19, 2020 registration statement.
A class action has commenced on behalf of certain shareholders in United States Oil Fund, LP. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) unbeknownst to investors, extraordinary market conditions in early 2020 made USO's purported investment objective and strategy unfeasible; (2) as excess oil supply increased and oil prices plummeted, the facilities available for storage in Cushing approached capacity, causing a "super contango" in which the futures prices for oil substantially exceeded the spot price; (3) instead of revealing the known impacts and risks to the Fund, USO held an offering of billions of dollars of USO shares in March 2020; and (4) as a result USO suffered billions of dollars in losses and was forced to abandon its investment strategy.
Shareholders may find more information at https://securitiesclasslaw.com/securities/united-states-oil-fund-lp-loss-submission-form/?id=8422&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com: